Answers are grounded in this paper and cite their sources.
Mitochondrial dysfunction alters dermal fibroblast proliferation, inflammatory secretion and extracellular matrix (ECM) turnover. This narrative review examines human dermal fibroblast studies, with tissue and clinical findings used to assess their relevance to skin aging. Inadequate nicotinamide adenine dinucleotide (NAD+) regeneration and impaired lysosomal degradation contribute to damaged mitochondrial accumulation, while mitochondrial nucleic acid leakage supports inflammatory signaling. Mitochondrial proteins regulate discrete steps of collagen processing, secretion and extracellular fiber formation, so their dysfunction can impair matrix deposition even when collagen gene expression is preserved. These processes governing growth arrest, secretory changes and ECM outcomes can be uncoupled: preserved total adenosine triphosphate (ATP) or increased intracellular collagen does not establish recovery of dermal structure. Mechanisms involving nucleic acid sensing and metabolic acetylation have been tested mainly in non-skin models. We compare mitochondrial, skin, and human evidence for ergothioneine, pyrroloquinoline quinone, α-lipoic acid, NAD+ precursors, and naturally derived bioactive compounds and related metabolites. Some short-term product trials report improvements in wrinkles or roughness, but mitochondrial mediation in human skin remains unresolved. Linking pathway interventions to extracellular deposition, tissue mechanics and compound concentrations in skin would clarify which mitochondrial changes matter for dermal aging.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: